MedPath

Biotheranostics, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Breast Cancer Index (BCI) Registry

Active, not recruiting
Conditions
Breast Cancer
Interventions
Diagnostic Test: Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test
First Posted Date
2021-05-06
Last Posted Date
2024-01-19
Lead Sponsor
Biotheranostics, Inc.
Target Recruit Count
3000
Registration Number
NCT04875351
Locations
🇺🇸

Southern Cancer Center, PC - Providence Hospital, Mobile, Alabama, United States

🇺🇸

Arizona Oncology Associates, PC - East Valley Cancer Center, Tempe, Arizona, United States

🇺🇸

New York Oncology Hematology, P.C. - Albany Cancer Center, Albany, New York, United States

and more 85 locations
© Copyright 2025. All Rights Reserved by MedPath